// App-Quantinova.ai

2514 : Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies

Researchers

Presenter

  • Andrew Bushmakin

Principal Investigators

  • Dafna Gladman

  • Oliver Fitz Gerald

  • Lara Fallon

  • Joseph Cappelleri

  • Ming-Ann Hsu

  • Laura Coates

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Pfizer, Groton, CT

  • University of Toronto, Toronto, ON, Canada

  • University College Dublin, Dublin 4, Ireland

  • Pfizer Canada, Montreal, QC, Canada

  • Pfizer Inc, Collegeville, PA

  • University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

  • United States

  • Canada

  • Ireland

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT01877668]

  • NCT01882439]

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved